Medtronic MiniMed 780G With Instinct Sensor Delivers Next-Level Diabetes Automation

Advanced glucose monitoring and automated insulin delivery for everyday use
Medtronic has begun U.S. commercial shipments of the MiniMed 780G system integrated with the Instinct sensor, marking a major step in automated diabetes care. Designed exclusively for MiniMed systems and based on Abbott’s most advanced CGM technology, the Instinct sensor offers discreet wear, extended longevity, and continuous real-time glucose data—critical for people managing type 1 diabetes.

Smarter insulin automation powered by next-generation sensing
The Instinct sensor combines a 15-day wear time with an ultra-small, ultra-thin profile. When connected to the MiniMed 780G system, it provides continuous glucose readings used by the algorithm to automatically adjust insulin dosing every five minutes. This closed-loop capability reduces the need for manual decision-making, helping users stay within target range more consistently and with less daily burden.

A seamless experience designed for comfort and reliability
The new sensor expands Medtronic’s growing CGM portfolio, complementing Simplera Sync and Guardian 4. Its discreet form factor, longer wear duration, and compatibility with the MiniMed algorithm offer a solution built for convenience and personalization. By integrating real-time sensing with automated insulin delivery, the system aims to improve day-to-day stability and support healthier long-term outcomes.

A milestone in building a flexible, smart-dosing ecosystem
With the MiniMed 780G and Instinct sensor now available nationwide, Medtronic strengthens its position in adaptive diabetes technology. The company’s ecosystem is designed to give users more choice, simplify diabetes management, and provide greater peace of mind for individuals and families. The launch reflects Medtronic’s commitment to making life with diabetes more predictable, freeing users to focus on living rather than constant glucose management.

www.medtronic.com